Business Description
![Biophytis SA Biophytis SA logo](https://static.gurufocus.com/logos/0C0000AY8C.png?14)
Biophytis SA
ISIN : US09076G2030
Share Class Description:
BPTSY: ADRCompare
Compare
Traded in other countries / regions
ALBPS.FranceBPTSY.USA0D1W.UK6XB3.Germany IPO Date
2021-02-10Description
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.98 | |||||
Equity-to-Asset | -0.32 | |||||
Debt-to-Equity | -1.58 | |||||
Debt-to-EBITDA | -0.4 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 59.1 | |||||
3-Year EPS without NRI Growth Rate | 52.8 | |||||
3-Year FCF Growth Rate | 47.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.16 | |||||
9-Day RSI | 58.02 | |||||
14-Day RSI | 51.4 | |||||
6-1 Month Momentum % | -71.88 | |||||
12-1 Month Momentum % | -92.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -117.8 | |||||
Shareholder Yield % | -25.37 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -105.19 | |||||
ROIC % | -111.41 | |||||
ROC (Joel Greenblatt) % | -3609.97 | |||||
ROCE % | -1713.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.14 | |||||
EV-to-Forward-EBIT | -0.15 | |||||
EV-to-EBITDA | -0.15 | |||||
EV-to-Forward-EBITDA | -0.15 | |||||
EV-to-Forward-Revenue | 1.79 | |||||
EV-to-FCF | -0.14 | |||||
Earnings Yield (Greenblatt) % | -714.29 | |||||
FCF Yield % | -612.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BPTSY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biophytis SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -130.295 | ||
Beta | 1.09 | ||
Volatility % | 44.69 | ||
14-Day RSI | 51.4 | ||
14-Day ATR ($) | 0.477509 | ||
20-Day SMA ($) | 7.3495 | ||
12-1 Month Momentum % | -92.36 | ||
52-Week Range ($) | 5.44 - 142 | ||
Shares Outstanding (Mil) | 0.29 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biophytis SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biophytis SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Biophytis SA Frequently Asked Questions
What is Biophytis SA(BPTSY)'s stock price today?
The current price of BPTSY is $8.00. The 52 week high of BPTSY is $142.00 and 52 week low is $5.44.
When is next earnings date of Biophytis SA(BPTSY)?
The next earnings date of Biophytis SA(BPTSY) is .
Does Biophytis SA(BPTSY) pay dividends? If so, how much?
Biophytis SA(BPTSY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |